Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans

This publication has 16 references indexed in Scilit:

• Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine
  The Journal of Infectious Diseases, 2006
• Excellent Safety and Tolerability of the Human Immunodeficiency Virus Type 1 pGA2/JS2 Plasmid DNA Priming Vector Vaccine in HIV Type 1 Uninfected Adults
  AIDS Research and Human Retroviruses, 2006
• Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
  Vaccine, 2004
• Safety and Immunogenicity of an HIV Subtype B and E Prime‐Boost Vaccine Combination in HIV‐Negative Thai Adults
  The Journal of Infectious Diseases, 2004
• A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans
  Journal of General Virology, 2004
• Genetic diversity of HIV in Africa
  AIDS, 2003
• Among 46 Near Full Length HIV Type 1 Genome Sequences from Rakai District, Uganda, Subtype D and AD Recombinants Predominate
  AIDS Research and Human Retroviruses, 2002
• HIV-1 Diversity and Vaccine Development
  Science, 2002
• New hope for an aids vaccine
  Nature Reviews Immunology, 2002
• Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines
  The Journal of Infectious Diseases, 2000